Helen of Troy Ltd (HELE) stock
Close on Nov 17, 2026Market cap $868.49MP/E –Yield –
Earnings
Helen of Troy's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Helen of Troy's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Nov 30, 2026 | Jan 7, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Aug 31, 2026 | Oct 8, 2026before the open | $440.90M | +2.1% | $0.19 | $0.79 | Release |
| Q1 FY2027ended May 31, 2026 | Jul 8, 2026before the open | $402.10M | +8.2% | $1.51 | $0.17 | Release |
| Q4 FY2026ended Feb 28, 2026 | Apr 23, 2026before the open | $470.00M | -3.3% | -$2.41 | $0.83 | Release |
| Q3 FY2026ended Nov 30, 2025 | Jan 8, 2026before the open | $512.80M | -3.4% | -$3.65 | $1.71 | Release |
| Q2 FY2026ended Aug 31, 2025 | Oct 9, 2025before the open | $431.80M | -8.9% | -$13.44 | $0.59 | Release |
| Q1 FY2026ended May 31, 2025 | Jul 10, 2025before the open | $371.70M | -10.8% | -$19.65 | $0.41 | Release |
| Q4 FY2025ended Feb 28, 2025 | Apr 24, 2025before the open | $485.90M | -0.7% | $2.22 | $2.33 | Release |
| Q3 FY2025ended Nov 30, 2024 | Jan 8, 2025before the open | $530.70M | -3.4% | $2.17 | $2.67 | Release |
| Q2 FY2025ended Aug 31, 2024 | Oct 9, 2024before the open | $474.20M | -3.5% | $0.74 | $1.21 | Release |
| Q1 FY2025ended May 31, 2024 | Jul 9, 2024before the open | $416.80M | -12.2% | $0.26 | $0.99 | Release |
| Q4 FY2024ended Feb 29, 2024 | Apr 24, 2024before the open | $489.20M | +0.9% | $1.79 | $2.45 | Release |
| Q3 FY2024ended Nov 30, 2023 | Jan 8, 2024before the open | $549.60M | -1.6% | $3.19 | $2.79 | Release |
| Q2 FY2024ended Aug 31, 2023 | Oct 4, 2023before the open | $491.60M | -5.7% | $1.14 | $1.74 | Release |
| Q1 FY2024ended May 31, 2023 | Jul 12, 2023after the close | $474.70M | -6.6% | $0.94 | $1.94 | Release |
| Q4 FY2023ended Feb 28, 2023 | May 1, 2023after the close | $484.60M | -16.7% | $1.50 | $2.01 | Release |
| Q3 FY2023ended Nov 30, 2022 | Jan 10, 2023after the close | $558.60M | -10.6% | $2.15 | $2.75 | Release |
| Q2 FY2023ended Aug 31, 2022 | Oct 6, 2022after the close | $521.40M | – | $1.28 | $2.27 | Release |
| Q1 FY2023ended May 31, 2022 | Jul 12, 2022before the open | $508.10M | – | $1.02 | $2.41 | Release |
| Q4 FY2022ended Feb 28, 2022 | Apr 27, 2022during market hours | $582.00M | – | $1.64 | $2.51 | Release |
| Q3 FY2022ended Nov 30, 2021 | Jan 11, 2022after the close | $624.90M | – | $3.10 | $3.72 | Release |
| Q2 FY2022ended Aug 31, 2021 | Oct 13, 2021after the close | – | – | – | – | Release |
| Q4 FY2021ended Feb 28, 2021 | May 3, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2021ended Nov 30, 2020 | Jan 11, 2021during market hours | – | – | – | – | Filing |
| Q2 FY2021ended Aug 31, 2020 | Oct 13, 2020during market hours | – | – | – | – | Filing |
| Q1 FY2021ended May 31, 2020 | Jul 13, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Helen of Troy's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Consolidated Net Sales | FY2027 | $1.77B – $1.82B | $1.76B – $1.83B | Raised | Oct 8, 2026 |
| Consolidated net sales (growth / decline) | FY2027 | -1% – +2% | -1.5% – +2.5% | Narrowed | Oct 8, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $203.00M – $210.00M | $190.00M – $197.00M | Raised | Oct 8, 2026 |
| Adjusted EBITDA (non-GAAP) growthnon-GAAP | FY2027 | +2.1% – +6.3% | – | New | Apr 23, 2026 |
| GAAP Diluted EPSGAAP | FY2027 | $3.63 – $4.26 | $3.57 – $4.18 | Raised | Oct 8, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $3.60 – $4.15 | $3.25 – $3.75 | Raised | Oct 8, 2026 |
| Adjusted diluted EPS (non-GAAP) (decline) growthnon-GAAP | FY2027 | -8.5% – +5.6% | – | New | Apr 23, 2026 |
| Free Cash Flow (1)(2)non-GAAP | FY2027 | $120.00M – $140.00M | $85.00M – $100.00M | Raised | Oct 8, 2026 |
| Free cash flow (non-GAAP) (decline)non-GAAP | FY2027 | -35.6% – -24.2% | – | New | Apr 23, 2026 |
| capital expenditures | FY2027 | $39.00M – $43.00M | $30.00M – $34.00M | Raised | Oct 8, 2026 |
| adjusted effective tax ratenon-GAAP | FY2027 | 24% – 26% | 25% – 27% | Lowered | Jul 8, 2026 |
| Cash Flow from OperationsGAAP | FY2027 | $119.00M – $130.00M | – | Raised | Jul 8, 2026 |
| GAAP effective tax rateGAAP | FY2027 | 27.2% – 29.7% | 28.1% – 30.5% | Lowered | Jul 8, 2026 |
| GAAP Net IncomeGAAP | FY2027 | $85.00M – $100.00M | – | Raised | Jul 8, 2026 |
| Interest expense | FY2027 | $45.50M – $47.50M | $47.00M – $49.00M | Lowered | Jul 8, 2026 |
| Net Income (GAAP)GAAP | FY2027 | $83.00M – $97.00M | – | Lowered | Apr 23, 2026 |
| Operating Cash Flow (GAAP)GAAP | FY2027 | $117.00M – $128.00M | – | New | Apr 23, 2026 |
| Weighted average diluted shares outstanding | FY2027 | 23.8 | – | New | Jul 8, 2026 |
Guidance vs results
The last range Helen of Troy gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adjusted Diluted EPS | $3.25 – $3.75 | $3.54Σ4Q | Within range |
| FY2026 | EPS (GAAP) | -$36.07 – -$35.57 | -$39.15Σ4Q | Below range |
| FY2026 | Revenue | $1.76B – $1.77B | $1.79BΣ4Q | Above range |
| FY2026 | Revenue growth | -7.8% – -7.1% | -6.36%Σ4Q | Above range |
| Q3 FY2026 | EPS (GAAP) | $1.85 – $2.05 | -$3.65 | Below range |
| Q3 FY2026 | non-GAAP adjusted diluted EPS | $1.55 – $1.80 | $1.71 | Within range |
| Q3 FY2026 | Revenue | $491.00M – $512.00M | $512.80M | Above range |
| Q3 FY2026 | Revenue growth | -7.5% – -3.5% | -3.37% | Above range |
| Q2 FY2026 | EPS (GAAP) | $0.56 – $0.68 | -$13.44 | Below range |
| Q2 FY2026 | non-GAAP adjusted diluted EPS | $0.45 – $0.60 | $0.59 | Within range |
| Q2 FY2026 | Revenue | $408.00M – $432.00M | $431.80M | Within range |
| FY2025 | EPS (GAAP) | $4.60 – $5.02 | $5.39Σ4Q | Above range |
| FY2025 | non-GAAP adjusted diluted EPS | $7.15 – $7.40 | $7.20Σ4Q | Within range |
| FY2025 | Revenue | $1.89B – $1.91B | $1.91BΣ4Q | Within range |
| FY2025 | Revenue growth | -5.8% – -4.6% | -4.86%Σ4Q | Within range |
Guidance history
Every forecast Helen of Troy put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 8, 2026 | capital expenditures | FY2027 | $39.00M – $43.00M | Raised |
| Oct 8, 2026 | Adjusted EBITDA | FY2027 | $203.00M – $210.00M | Raised |
| Oct 8, 2026 | Adjusted Diluted EPS | FY2027 | $3.60 – $4.15 | Raised |
| Oct 8, 2026 | GAAP Diluted EPS | FY2027 | $3.63 – $4.26 | Raised |
| Oct 8, 2026 | Free Cash Flow (1)(2) | FY2027 | $120.00M – $140.00M | Raised |
| Oct 8, 2026 | Consolidated net sales (growth / decline) | FY2027 | -1% – +2% | Narrowed |
| Oct 8, 2026 | Consolidated Net Sales | FY2027 | $1.77B – $1.82B | Raised |
| Jul 8, 2026 | capital expenditures | FY2027 | $30.00M – $34.00M | Raised |
| Jul 8, 2026 | Adjusted EBITDA (1) | FY2027 | $190.00M – $197.00M | Reaffirmed |
| Jul 8, 2026 | Adjusted Diluted EPS | FY2027 | $3.25 – $3.75 | Reaffirmed |
| Jul 8, 2026 | GAAP Diluted EPS | FY2027 | $3.57 – $4.18 | Reaffirmed |
| Jul 8, 2026 | Free Cash Flow (1)(2) | FY2027 | $85.00M – $100.00M | Reaffirmed |
| Jul 8, 2026 | Weighted average diluted shares outstanding | FY2027 | 23.8 | New |
| Jul 8, 2026 | GAAP effective tax rate | FY2027 | 27.2% – 29.7% | Lowered |
| Jul 8, 2026 | adjusted effective tax rate | FY2027 | 24% – 26% | Lowered |
| Jul 8, 2026 | Interest expense | FY2027 | $45.50M – $47.50M | Lowered |
| Jul 8, 2026 | GAAP Net Income | FY2027 | $85.00M – $100.00M | Raised |
| Jul 8, 2026 | Cash Flow from Operations | FY2027 | $119.00M – $130.00M | Raised |
| Jul 8, 2026 | Consolidated Net Sales | FY2027 | $1.76B – $1.83B | Raised |
| Jul 8, 2026 | Net sales revenue (decline) growth | FY2027 | -1.5% – +2.5% | Raised |
| Jul 8, 2026 | Home & Outdoor Net Sales | FY2027 | $859.00M – $884.00M | Lowered |
| Jul 8, 2026 | Beauty & Wellness Net Sales | FY2027 | $900.00M – $947.00M | Raised |
| Apr 23, 2026 | capital expenditures | FY2027 | $28.00M – $32.00M | New |
| Apr 23, 2026 | Adjusted EBITDA (non-GAAP) growth | FY2027 | +2.1% – +6.3% | New |
| Apr 23, 2026 | Adjusted EBITDA (Non-GAAP) | FY2027 | $190.00M – $197.00M | New |
| Apr 23, 2026 | Adjusted diluted EPS (non-GAAP) (decline) growth | FY2027 | -8.5% – +5.6% | New |
| Apr 23, 2026 | Adjusted Diluted EPS (Non-GAAP) | FY2027 | $3.25 – $3.75 | New |
| Apr 23, 2026 | Diluted EPS (GAAP) | FY2027 | $3.57 – $4.18 | New |
| Apr 23, 2026 | Free cash flow (non-GAAP) (decline) | FY2027 | -35.6% – -24.2% | New |
| Apr 23, 2026 | Free Cash Flow | FY2027 | $85.00M – $100.00M | New |
| Apr 23, 2026 | GAAP effective tax rate | FY2027 | 28.1% – 30.5% | New |
| Apr 23, 2026 | adjusted effective tax rate | FY2027 | 25% – 27% | New |
| Apr 23, 2026 | interest expense | FY2027 | $47.00M – $49.00M | New |
| Apr 23, 2026 | Operating Cash Flow (GAAP) | FY2027 | $117.00M – $128.00M | New |
| Apr 23, 2026 | Net Income (GAAP) | FY2027 | $83.00M – $97.00M | Lowered |
| Apr 23, 2026 | Net sales revenue (decline) growth | FY2027 | -2% – +2% | New |
| Apr 23, 2026 | Consolidated Net Sales | FY2027 | $1.75B – $1.82B | New |
| Apr 23, 2026 | Home & Outdoor Net Sales | FY2027 | $854.00M – $882.00M | Lowered |
| Apr 23, 2026 | Beauty & Wellness Net Sales | FY2027 | $897.00M – $940.00M | Raised |
| Jan 8, 2026 | Adjusted Diluted EPS | FY2026 | $3.25 – $3.75 | Lowered |
| Jan 8, 2026 | GAAP Diluted Loss Per Share | FY2026 | -$36.07 – -$35.57 | Lowered |
| Jan 8, 2026 | reported GAAP effective tax rate | FY2026 | -8.9% – -8.7% | Lowered |
| Jan 8, 2026 | adjusted effective tax rate | FY2026 | 13.4% – 14.7% | Lowered |
| Jan 8, 2026 | expected interest expense | FY2026 | $58.00M – $59.00M | Raised |
| Jan 8, 2026 | Net sales revenue decline | FY2026 | -7.8% – -7.1% | Narrowed |
| Jan 8, 2026 | Consolidated Net Sales | FY2026 | $1.76B – $1.77B | Narrowed |
| Jan 8, 2026 | Home & Outdoor net sales | FY2026 | $812.00M – $819.00M | Lowered |
| Jan 8, 2026 | Beauty & Wellness net sales | FY2026 | $946.00M – $954.00M | Raised |
| Oct 9, 2025 | adjusted diluted EPS decline | FY2026 | -47.7% – -40.7% | New |
| Oct 9, 2025 | adjusted diluted EPS decline | Q3 FY2026 | -41.9% – -32.6% | New |
| Oct 9, 2025 | non-GAAP adjusted diluted earnings per share | FY2026 | $3.75 – $4.25 | New |
| Oct 9, 2025 | non-GAAP adjusted diluted EPS | Q3 FY2026 | $1.55 – $1.80 | New |
| Oct 9, 2025 | GAAP diluted loss per share | FY2026 | -$29.90 – -$29.40 | New |
| Oct 9, 2025 | GAAP diluted EPS | Q3 FY2026 | $1.85 – $2.05 | New |
| Oct 9, 2025 | reported GAAP effective tax rate | FY2026 | -0.8% – -0.6% | New |
| Oct 9, 2025 | adjusted effective tax rate | FY2026 | 15% – 16% | New |
| Oct 9, 2025 | expected interest expense | FY2026 | $56.00M – $57.00M | New |
| Oct 9, 2025 | reported GAAP effective tax rate | Q3 FY2026 | -16% – -10% | New |
| Oct 9, 2025 | adjusted effective tax rate | Q3 FY2026 | 22% – 25% | New |
| Oct 9, 2025 | consolidated net sales revenue decline | FY2026 | -8.8% – -6.7% | New |
| Oct 9, 2025 | consolidated net sales revenue | FY2026 | $1.74B – $1.78B | New |
| Oct 9, 2025 | net sales revenue decline | Q3 FY2026 | -7.5% – -3.5% | New |
| Oct 9, 2025 | net sales revenue | Q3 FY2026 | $491.00M – $512.00M | New |
| Jul 10, 2025 | non-GAAP adjusted diluted EPS | Q2 FY2026 | $0.45 – $0.60 | New |
| Jul 10, 2025 | GAAP diluted earnings per share | Q2 FY2026 | $0.56 – $0.68 | New |
| Jul 10, 2025 | consolidated net sales revenue | Q2 FY2026 | $408.00M – $432.00M | New |
| Jan 8, 2025 | adjusted EBITDA decline | FY2025 | -13.2% – -12.3% | New |
| Jan 8, 2025 | adjusted EBITDA | FY2025 | $292.00M – $295.00M | New |
| Jan 8, 2025 | adjusted diluted EPS decline | FY2025 | -19.8% – -16.9% | New |
| Jan 8, 2025 | non-GAAP adjusted diluted EPS | FY2025 | $7.15 – $7.40 | New |
| Jan 8, 2025 | GAAP diluted EPS | FY2025 | $4.60 – $5.02 | New |
| Jan 8, 2025 | free cash flow | FY2025 | $145.00M – $155.00M | New |
| Jan 8, 2025 | weighted average diluted shares outstanding | FY2025 | 23.1 | New |
| Jan 8, 2025 | net leverage ratio | FY2025 | 2.75 – 2.85 | New |
| Jan 8, 2025 | reported GAAP effective tax rate | FY2025 | 25.8% – 27.6% | New |
| Jan 8, 2025 | adjusted effective tax rate | FY2025 | 18.6% – 19.4% | New |
| Jan 8, 2025 | interest expense | FY2025 | $50.30M – $51.70M | New |
| Jan 8, 2025 | consolidated net sales revenue decline | FY2025 | -5.8% – -4.6% | New |
| Jan 8, 2025 | consolidated net sales revenue | FY2025 | $1.89B – $1.91B | New |
| Oct 9, 2024 | adjusted EBITDA | FY2025 | $287.00M – $297.00M | Reaffirmed |
| Oct 9, 2024 | non-GAAP adjusted diluted EPS | FY2025 | $7.00 – $7.50 | Reaffirmed |
| Oct 9, 2024 | GAAP diluted EPS | FY2025 | $4.69 – $5.45 | Reaffirmed |
| Oct 9, 2024 | free cash flow | FY2025 | $180.00M – $200.00M | Lowered |
| Oct 9, 2024 | net leverage ratio | FY2025 | 1.8 – 1.9 | New |
| Oct 9, 2024 | consolidated net sales revenue | FY2025 | $1.89B – $1.94B | Reaffirmed |
| Jul 9, 2024 | adjusted EBITDA | FY2025 | $287.00M – $297.00M | Lowered |
| Jul 9, 2024 | non-GAAP adjusted diluted EPS | FY2025 | $7.00 – $7.50 | Lowered |
| Jul 9, 2024 | GAAP diluted EPS | FY2025 | $4.69 – $5.45 | Lowered |
| Jul 9, 2024 | free cash flow | FY2025 | $220.00M – $240.00M | Lowered |
| Jul 9, 2024 | consolidated net sales revenue | FY2025 | $1.89B – $1.94B | Lowered |
| Apr 24, 2024 | adjusted EBITDA | FY2025 | $324.00M – $331.00M | New |
| Apr 24, 2024 | non-GAAP adjusted diluted EPS | FY2025 | $8.70 – $9.20 | New |
| Apr 24, 2024 | GAAP diluted EPS | FY2025 | $6.68 – $7.45 | New |
| Apr 24, 2024 | free cash flow | FY2025 | $255.00M – $275.00M | New |
| Apr 24, 2024 | consolidated net sales revenue | FY2025 | $1.97B – $2.03B | New |
| Jan 8, 2024 | consolidated adjusted EBITDA | FY2024 | $330.00M – $335.00M | Lowered |
| Jan 8, 2024 | non-GAAP adjusted diluted EPS | FY2024 | $8.60 – $8.85 | Narrowed |
| Jan 8, 2024 | GAAP diluted EPS | FY2024 | $6.67 – $7.05 | Raised |
| Jan 8, 2024 | free cash flow | FY2024 | $250.00M – $270.00M | Reaffirmed |
| Jan 8, 2024 | consolidated net sales revenue | FY2024 | $1.98B – $2.00B | Narrowed |
| Oct 4, 2023 | consolidated adjusted EBITDA | FY2024 | $338.00M – $348.00M | Reaffirmed |
| Oct 4, 2023 | non-GAAP adjusted diluted EPS | FY2024 | $8.50 – $9.00 | Reaffirmed |
| Oct 4, 2023 | GAAP diluted EPS | FY2024 | $6.36 – $7.03 | Raised |
| Oct 4, 2023 | Free cash flow | FY2024 | $250.00M – $270.00M | Reaffirmed |
| Oct 4, 2023 | net leverage ratio | FY2024 | 1.85 – 2 | Reaffirmed |
| Oct 4, 2023 | consolidated net sales revenue | FY2024 | $1.97B – $2.02B | Reaffirmed |
| Jul 12, 2023 | consolidated adjusted EBITDA | FY2024 | $338.00M – $348.00M | Reaffirmed |
| Jul 12, 2023 | non-GAAP adjusted diluted EPS | FY2024 | $8.50 – $9.00 | Reaffirmed |
| Jul 12, 2023 | GAAP diluted EPS | FY2024 | $3.81 – $4.67 | Lowered |
| Jul 12, 2023 | Free cash flow | FY2024 | $250.00M – $270.00M | Reaffirmed |
| Jul 12, 2023 | net leverage ratio | FY2024 | 1.85 – 2 | New |
| Jul 12, 2023 | consolidated net sales revenue | FY2024 | $1.97B – $2.02B | Reaffirmed |
| May 1, 2023 | consolidated adjusted EBITDA | FY2024 | $338.00M – $348.00M | New |
| May 1, 2023 | non-GAAP adjusted diluted EPS | FY2024 | $8.50 – $9.00 | New |
| May 1, 2023 | consolidated GAAP diluted EPS | FY2024 | $3.98 – $4.84 | New |
| May 1, 2023 | Free cash flow | FY2024 | $250.00M – $270.00M | New |
| May 1, 2023 | consolidated net sales revenue | FY2024 | $1.97B – $2.02B | New |
| Jan 10, 2023 | capital and intangible asset expenditures | FY2023 | $175.00M – $185.00M | Lowered |
| Jan 10, 2023 | consolidated non-GAAP adjusted diluted EPS | FY2023 | $9.20 – $9.40 | Raised |
| Jan 10, 2023 | consolidated GAAP diluted EPS | FY2023 | $4.82 – $5.11 | Raised |
| Jan 10, 2023 | consolidated net sales revenue | FY2023 | $2.03B – $2.05B | Lowered |
| Oct 6, 2022 | capital and intangible asset expenditures | FY2023 | $180.00M – $190.00M | Lowered |
| Oct 6, 2022 | consolidated non-GAAP adjusted diluted EPS | FY2023 | $9.00 – $9.40 | Lowered |
| Oct 6, 2022 | consolidated GAAP diluted EPS | FY2023 | $4.26 – $4.93 | Lowered |
| Oct 6, 2022 | consolidated net sales revenue | FY2023 | $2.00B – $2.05B | Lowered |
| Jul 12, 2022 | capital and intangible asset expenditures | FY2023 | $180.00M – $200.00M | Lowered |
| Jul 12, 2022 | consolidated non-GAAP adjusted diluted EPS | FY2023 | $9.85 – $10.35 | Lowered |
| Jul 12, 2022 | consolidated GAAP diluted EPS | FY2023 | $6.51 – $7.11 | Lowered |
| Jul 12, 2022 | consolidated net sales revenue | FY2023 | $2.15B – $2.20B | New |
| Apr 27, 2022 | capital and intangible asset expenditures | FY2023 | $180.00M – $205.00M | New |
| Apr 27, 2022 | consolidated non-GAAP adjusted diluted EPS | FY2023 | $12.73 – $13.03 | New |
| Apr 27, 2022 | consolidated GAAP diluted EPS | FY2023 | $9.92 – $10.38 | New |
| Apr 27, 2022 | consolidated net sales revenue | FY2023 | $2.38B – $2.42B | New |
| Jan 11, 2022 | capital asset expenditures | FY2022 | $85.00M – $110.00M | New |
| Jan 11, 2022 | consolidated non-GAAP adjusted diluted EPS | FY2022 | $11.73 – $11.93 | New |
| Jan 11, 2022 | consolidated GAAP diluted EPS | FY2022 | $8.25 – $8.59 | New |
| Jan 11, 2022 | reported consolidated GAAP effective tax rate | FY2022 | 13% – 14% | New |
| Jan 11, 2022 | consolidated adjusted effective tax rate | FY2022 | 10.8% – 11.7% | New |
| Jan 11, 2022 | consolidated net sales revenue | FY2022 | $2.10B – $2.12B | New |
| Jan 11, 2022 | Core net sales revenue | FY2022 | $2.06B – $2.08B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Helen of Troy filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Results
See a number that looks wrong?